Table 3.
Association of total infection rate of COVID-19/1000 people and total mortality rate of COVID-19/1000 confirmed cases with respiratory vaccinations, age at vaccination, and vaccine years in the world between 1980 and 2018
Controlling factors | Dependent variable | |||
---|---|---|---|---|
Total infection rate/1000 people | Total mortality rate/1000 confirmed cases | |||
Respiratory vaccine coverage (n = 186) | P-Value | HR (95% CI) | P-value | HR (95% CI) |
Economic characteristics | <0.001 | <0.001 | ||
Low-income economies | ||||
Lower middle-income economies | 2.73 (2.75-2.70) | 3.31 (3.46-3.16) | ||
Upper middle-income economies | 11.83 (11.84-11.70) | 20.28 (21.42-19.20) | ||
High-income economies | ||||
185.08 (196.14-174.62) | ||||
57.21 (57.67-56.32) | ||||
Health system | 0.481 | 0.161 | ||
Mandatory individual account system | ||||
Social assistance system | ||||
Social insurance | 3.80 (3.82-3.77) | 1.34 (1.35-1.34) | ||
Social insurance and social assistance system | 3.41 (3.44-3.36) | 5.58 (5.94-5.25) | ||
13.46 (13.62-13.30) | 33.00 (35.19-30.91) | |||
Universal, social insurance, and social assistance system | 10.34 (10.45-10.27) | 23.40 (24.68-21.97) | ||
BCG coverage | 0.681 | 0.030 | ||
With universal coverage vaccine | ||||
Without universal coverage vaccine | 426.528 (447.221-407.665) | 286.837 (284.398-289.317) | ||
MCV2 coverage | 0.216 | 0.271 | ||
With universal coverage vaccine | ||||
Without universal coverage vaccine | 7.602 (7.596-7.608) | 108.994 (108.627-109.364) | ||
PCV coverage | 0.657 | 0.485 | ||
With universal coverage vaccine | ||||
Without universal coverage vaccine | 7.319 (7.307-7.331) | 90.609 (90.080- 91.143) | ||
Male population | 0.877 | 0.230 | ||
Female population | 0.897 | NA | 0.231 | NA |
Note: Multivariate analysis model was performed for statistical analyses.
The bold numbers shows the significant difference.
Vaccine years: The number of years that the vaccine was applied since it commencement.
The first row was considered the reference in calculating the HR and 95% CI.
Abbreviation: NA, not applicable.